肠道微生物群在某些自身免疫性疾病的发展中的作用
Xiaojing Cui1,2, Yanguang Cong1,2
1Department of Clinical Laboratory, The First Dongguan Affiliated Hospital, Guangdong Medical University, Dongguan, Guangdong Province, 523710, People's Republic of China.
Journal of inflammation research
|March 31, 2025
概括
肠道微生物组显著影响免疫系统的功能和耐受性. 肠道细菌的破坏与自身免疫性疾病有关,这表明微生物组调节作为治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
- 胃肠病学 胃肠病学
背景情况:
- 肠道微生物群在维持宿主免疫恒温中发挥着至关重要的作用.
- 它通过免疫耐受性,免疫细胞分化和调节物质的新陈代谢与免疫系统相互作用.
- 肠道微生物组的改变可能会破坏粘膜壁垒,导致免疫激活和潜在的自身免疫反应.
研究的目的:
- 审查了解微生物组在自身免疫性疾病发展中的作用的最新进展.
- 探索基于微生物组的治疗策略,用于自身免疫性疾病.
- 突出肠道微生物群在自身免疫性疾病的背景下的重要性.
主要方法:
- 关于肠道微生物组和自身免疫疾病的当前研究的文献综述.
- 分析微生物群影响免疫系统的机制.
- 检查针对微生物组调节的治疗干预措施.
主要成果:
- 肠道微生物组是免疫系统调节和功能的组成部分.
- 失生症 (微生物组失衡) 与免疫力受损和自身免疫性疾病风险增加有关.
- 针对微生物组的治疗方法在治疗自身免疫性疾病方面表现有前途.
结论:
- 肠道微生物组是自身免疫性疾病的发病的一个关键因素.
- 了解这些复杂的宿主-微生物相互作用对于开发新的治疗策略至关重要.
- 调节肠道微生物组为未来的自身免疫性疾病治疗提供了一个有希望的途径.
相关概念视频
Autoimmune Disorders
348
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
348
T Cell Types and Functions
689
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
689
Irritable Bowel Syndrome I: Introduction
210
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
210
Anatomy of the Intestines
70.8K
Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
70.8K
Inflammatory Bowel Disease IV: Pharmacological Management
82
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
82
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
109
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
109


